Nascent Biotech nascentbiotech.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Nascent Biotech (NBI) is a biotechnology company developing human Monoclonal Antibodies (mAb's) for immunotherapy of cancer. Its lead therapeutic candidate, Pritumumab, was the first human antibody ever developed to treat a cancer patient and has been validated in 249 patients in Japan. The company is now developing a new clinical protocol and Initial New Drug (IND) package for commencement of new clinical trials to be conducted in the United States under the guidance of the US Food and Drug Adm...Show all

Nascent Biotech (NBI) is a biotechnology company developing human Monoclonal Antibodies (mAb's) for immunotherapy of cancer. Its lead therapeutic candidate, Pritumumab, was the first human antibody ever developed to treat a cancer patient and has bee...Show all

Company (IPO / Went public)

Phone:

Fax:



Fort Lauderdale,
Florida, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Nascent Biotech $0M Jul 29, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Nascent Biotech Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Enhanced delivery of drugs to the brain Sep 09, 2016 Application